Stockscreener 앱 받기
13.58
4.77%
-0.68
시장 영업 전:
13.50
-0.08
-0.59%
전일 마감가:
$14.26
열려 있는:
$14.43
하루 거래량:
274.35K
Relative Volume:
0.82
시가총액:
$252.11M
수익:
$62.81M
순이익/손실:
$-13.75M
주가수익비율:
-16.97
EPS:
-0.8
순현금흐름:
$153.00K
1주 성능:
-12.16%
1개월 성능:
-33.10%
6개월 성능:
+13.64%
1년 성능:
+207.24%
1일 변동 폭
$13.57
$14.87
1주일 범위
$13.57
$15.51
52주 변동 폭
$3.9914
$22.25
Optimizerx Corp Stock (OPRX) Company Profile
명칭
Optimizerx Corp
전화
248-651-6558
주소
260 CHARLES STREET, WALTHAM, MI
OPRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
13.58 | 265.82M | 62.81M | -13.75M | 153.00K | -0.80 |
|
VEEV
Veeva Systems Inc
|
270.50 | 44.75B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
65.69 | 12.29B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
100.73 | 8.92B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
46.42 | 9.04B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
34.79 | 6.66B | 906.14M | -52.62M | 89.62M | -0.3621 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-08 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-12-20 | 개시 | Stephens | Equal-Weight |
| 2024-07-25 | 재개 | B. Riley Securities | Buy |
| 2024-04-04 | 개시 | JMP Securities | Mkt Outperform |
| 2024-01-03 | 개시 | Barclays | Equal Weight |
| 2023-02-02 | 재개 | B. Riley Securities | Buy |
| 2022-11-01 | 개시 | Stifel | Buy |
| 2022-07-15 | 개시 | SVB Leerink | Outperform |
| 2021-10-18 | 재개 | B. Riley Securities | Buy |
| 2021-04-13 | 개시 | RBC Capital Mkts | Outperform |
| 2019-01-03 | 개시 | William Blair | Outperform |
모두보기
Optimizerx Corp 주식(OPRX)의 최신 뉴스
Connor Clark & Lunn Investment Management Ltd. Makes New Investment in OptimizeRx Corp. $OPRX - Defense World
Is OptimizeRx Corporation stock attractive for growth ETFs2025 Bull vs Bear & Daily Growth Stock Investment Tips - newser.com
P.A.W. Capital Corp Invests $675,000 in OptimizeRx Corp. $OPRX - MarketBeat
Can OptimizeRx Corporation stock deliver surprise earnings beat2025 Bull vs Bear & Verified Entry Point Detection - newser.com
Is a relief rally coming for OptimizeRx Corporation holdersInsider Selling & Fast Gain Swing Alerts - newser.com
Can OptimizeRx Corporation stock sustain market leadershipJuly 2025 Update & Technical Pattern Alert System - newser.com
Automated trading signals detected on OptimizeRx CorporationJuly 2025 WrapUp & Reliable Entry Point Trade Alerts - newser.com
Stephens Issues Pessimistic Forecast for OptimizeRx (NASDAQ:OPRX) Stock Price - MarketBeat
OptimizeRx : Corporate PresentationNovember 2025 - MarketScreener
How OptimizeRx Corporation stock performs in rate cut cyclesJuly 2025 Pullbacks & AI Optimized Trading Strategy Guides - newser.com
OptimizeRx (OPRX) Price Target Increased by 24.79% to 24.82 - Nasdaq
OptimizeRx (OPRX) Analyst Rating Update: Stephens & Co. Lowers P - GuruFocus
Los Angeles Capital Management LLC Makes New $349,000 Investment in OptimizeRx Corp. $OPRX - MarketBeat
When is the best time to exit OptimizeRx Corporation2025 Market Sentiment & Safe Entry Zone Tips - newser.com
Published on: 2025-11-16 12:30:34 - newser.com
Will OptimizeRx Corporation stock maintain momentum in 20252025 Valuation Update & AI Powered Market Trend Analysis - newser.com
Can a trend reversal in OptimizeRx Corporation lead to recoveryJuly 2025 Outlook & Reliable Intraday Trade Plans - newser.com
OptimizeRx (OPRX) Q3 2025 Earnings Call Transcript - Yahoo Finance
OptimizeRx (NASDAQ:OPRX) Issues Earnings Results, Beats Expectations By $0.17 EPS - MarketBeat
OptimizeRx (NASDAQ:OPRX) Raised to Strong-Buy at Wall Street Zen - MarketBeat
ETFs Investing in OptimizeRx Corporation Stocks - TradingView
OptimizeRx Corporation (NASDAQ:OPRX) Q3 2025 Earnings Call Transcript - Insider Monkey
Citizens Maintains OptimizeRx (OPRX) Market Outperform Recommendation - MSN
OptimizeRx (NASDAQ:OPRX) Stock Price Expected to Rise, Citizens Jmp Analyst Says - MarketBeat
How Recent Upgrades Are Changing the OptimizeRx Story According to Analysts - Yahoo Finance
OptimizeRx Corp. (OPRX) Tops Q3 Earnings and Revenue Estimates - sharewise.com
[Form 4] OptimizeRx Corp Insider Trading Activity - Stock Titan
[10-Q] OptimizeRx Corp Quarterly Earnings Report | OPRX SEC FilingForm 10-Q - Stock Titan
OptimizeRx (OPRX) Analyst Rating Update: Price Target Raised to $24.00 | OPRX Stock News - GuruFocus
OptimizeRx Delivers Big Earnings Beat And Raises Outlook Again - Finimize
OptimizeRx Corp (OPRX) Q3 2025 Earnings Call Highlights: Transitioning to Predictive Revenue ... By GuruFocus - Investing.com Canada
OptimizeRx Corp (OPRX) Q3 2025 Earnings Call Highlights: Transitioning to Predictive Revenue ... - Yahoo Finance
Vanguard Group Inc's Strategic Acquisition of OptimizeRx Corp Sh - GuruFocus
Earnings call transcript: OptimizeRx’s Q3 2025 Earnings Beat Expectations - Investing.com
OPTIMIZERx earnings beat by $0.16, revenue topped estimates - Investing.com
OptimizeRx Corp reports results for the quarter ended September 30Earnings Summary - TradingView
OptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance - The Manila Times
[8-K] OptimizeRx Corp Reports Material Event | OPRX SEC FilingForm 8-K - Stock Titan
OptimizeRx (Nasdaq: OPRX) raises full-year outlook to $105M-$109M; updates EBITDA view - Stock Titan
Will OptimizeRx Corporation stock deliver better than expected guidanceWeekly Trend Recap & High Return Trade Opportunity Guides - newser.com
Optimizerx Corp (OPRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.18%
0.03%
자본화:
|
볼륨(24시간):